Phosphorylated peptides are naturally processed and presented by major histocompatibility complex class I molecules in vivo

Journal of Experimental Medicine

Volumn 192, Issue 12, 2000, Pages 1755-1762

  Zarling, Angela L ^a   Ficarro, Scott B ^b   White, Forest M ^b   Shabanowitz, Jeffrey ^b   Hunt, Donald F ^b   Engelhard, Victor H ^a,b  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Cytotoxic T lymphocytes; Mass spectrometry; MHC class I; Phosphopeptides; Posttranslational protein processing

Indexed keywords

CD8 ANTIGEN; EPITOPE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PEPTIDE; PHOSPHOPEPTIDE;

ANTIGEN PRESENTATION; ANTIGEN RECOGNITION; ARTICLE; CYTOTOXIC T LYMPHOCYTE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOSTIMULATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MASS SPECTROMETRY; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN PROCESSING; T LYMPHOCYTE;

ALLELES; AMINO ACID SEQUENCE; ANIMALS; ANTIGEN PRESENTATION; ANTIGENS; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE; CYTOKINES; EPITOPES, T-LYMPHOCYTE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HUMANS; INTERFERON TYPE II; MASS SPECTROMETRY; MICE; MICE, INBRED C57BL; PHOSPHOPEPTIDES;

EID: 0034684676     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.192.12.1755     Document Type: Article

References (50)

1. The biochemistry and cell biology of antigen processing and presentation
2. The nature of the MHC class I peptide loading complex
3. Structure of peptides associated with MHC class I molecules
4. Mass-spectrometric evaluation of HLA-A *0201-associated peptides identifies dominant naturally processed forms of CTL epitopes from MART-1 and gp100
5. Characterization of peptides bound to the class I MHC molecule HLA-A2.1 by mass spectrometry
6. Characteristics of endogenous peptides eluted from the class I MHC molecule HLA-B7 determined by mass spectometry and computer modeling
7. Analysis of the structure of naturally processed peptides bound by class I and class II major histocompatibility complex molecules
8. Sequence analysis of peptides presented to the immune system by class I and class II MHC molecules
9. Isolation and characterization of naturally processed peptides bound by class II molecules and peptides presented by normal and mutant antigen-presenting cells
10. An HLA-A2-restricted tyrosinase antigen on melanoma cells results from posttranslational modification and suggests a novel pathway for processing of membrane proteins
11. The class I antigen-processing pathway for the membrane protein tyrosinase involves translation in the endoplasmic reticulum and processing in the cytosol
12. The HLA-A*0201-restricted H-Y antigen contains a posttranslationally modified cysteine that significantly affects T cell recognition
13. Human melanoma patients recognize an HLA-A1-restricted CTL epitope from tyrosinase containing two cysteine residues: Implications for tumor vaccine development
14. Cutting edge: The HLA-A*0101-restricted HY minor histocompatibility antigen originates from DFFRY and contains a cysteinylated cysteine residue as identified by a novel mass spectrometric technique
15. Presentation of cytosolic glycosylated peptides by human class I major histocompatibility complex molecules in vivo
16. Posttranslational side chain modification of a viral epitope results in diminished recognition by specific T cells
17. Modification of cysteine residues in vitro and in vivo affects the immunogenicity and antigenicity of major histocompatibility complex class I-restricted viral determinants
18. The peptide recognized by HLA-A68.2-restricted, squamous cell carcinoma of the lung-specific cytotoxic T lymphocytes is derived from a mutated elongation factor 2 gene
19. Phosphorylated peptides can be transported by TAP molecules, presented by class I MHC molecules, and recognized by phosphopeptide-specific CTL
20. Cytotoxic T-lymphocyte response to autologous human squamous cell cancer of the lung: Epitope reconstitution with peptides extracted from HLA-Aw68
21. Genes regulating HLA class I antigen expression in T-B lymphoblast hybrids
22. HLA-A2.1-associated peptides from a mutant cell line: A second pathway of antigen presentation
23. Association of human class I MHC alleles with the adenovirus E3/19K protein
24. Construction of novel class I histocompatibility antigens by interspecies exon shuffling
25. Partial purification and some properties of BB7.2. A cytotoxic monoclonal antibody with specificity for HLA-A2 and a variant of HLA-A28
26. Use of a monoclonal antibody (W6/32) in structural studies of HLA-A, B, C antigens
27. Structural and genetic analyses of HLA class I molecules using monoclonal xenoantibodies
28. Sub-femtomole MS and MS/MS peptide sequence analysis using nano-HPLC micro-ESI fourier transform ion cyclotron resonance mass spectrometry
29. Fragmentation of phosphopeptides in an ion trap mass spectrometer
30. Importance of MHC class 1 α2 and α3 domains in the recognition of self and non-self MHC molecules
31. The density of peptides displayed by dendritic cells affects immune responses to human tyrosinase and gp100 in HLA-A2 transgenic mice
32. Self-tolerance to the murine homologue of a tyrosinase-derived melanoma antigen: Implications for tumor immunotherapy
33. Naturally processed peptides longer than nine amino acid residues bind to the class I MHC molecule HLA-A2.1 with high affinity and in different conformations
34. Immobilized metal ion affinity chromatography
35. Identification by electrospray ionization mass spectrometry of the sites of tyrosine phosphorylation induced in activated Jurkat T cells on the protein tyrosine kinase ZAP-70
36. Selective detection and sequencing of phosphopeptides at the femtomole level by mass spectrometry
37. Parent ion scans of unseparated peptide mixtures
38. Processing of major histocompatability class I-restricted antigens in the endoplasmic reticulum
39. Protein tyrosine kinases: Structure, substrate specificity, and drug discovery
40. Phosphorylation-dependent conformational changes induce a switch in the actin-binding function of MARCKS
41. Two antigens recognized by autologous cytolytic T lymphocytes on a melanoma result from a single point mutation in an essential housekeeping gene
42. Oncogenes and signal transduction
43. Cooperation between oncogenes
44. Structure of peptides associated with class I and class II MHC molecules
45. Consensus motifs and peptide ligands of MHC class I molecules
46. Protein kinase recognition sequence motifs
47. Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma
48. Direct identification of tumor-associated peptide antigens
49. The makings of a tumor rejection antigen
50. Phosphorylation of the tumor suppressor protein p53 by mitogen-activated protein kinases